Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;23(13):18-00136.
doi: 10.2807/1560-7917.ES.2018.23.13.18-00136.

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017

Anke Kohlenberg  1 , Marc J Struelens  1 , Dominique L Monnet  1 , Diamantis Plachouras  1 ; Candida auris survey collaborative group  2
Affiliations

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017

Anke Kohlenberg et al. Euro Surveill. 2018 Mar.

Abstract

During 2013-2017, 620 cases of Candida auris were reported in the European Union/European Economic Area - 466 (75.2%) colonisations, 110 (17.7%) bloodstream infections, 40 (6.5%) other infections and four cases (0.6%) of unknown colonisation/infection status - the majority from four large outbreaks. Survey results showed that several countries lacked laboratory capacity and/or information on the occurrence of cases at national level. To prevent further spread, adequate laboratory capacity and infection control preparedness is required in Europe.

Keywords: Candida auris; laboratory capacity; multidrug-resistance; mycology; outbreaks; preparedness and response; surveillance.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Gilead Sciences reimbursed Public Health England for the time of Colin Brown for delivering an educational update on C. auris at a fungal conference they organised. CB did not receive any direct personal funding. All other authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Number of reported Candida auris cases by year and infection or colonisation, European Union and European Economic Area countries, 2013–2017 (n = 620)a
Figure 2
Figure 2
Geographic distribution of Candida auris cases reported in European Union / European Economic Area countries, 2013–2017 (n = 620)a
See this image and copyright information in PMC

References

    1. European Centre for Disease Prevention and Control (ECDC). Candida auris in healthcare settings -Europe. Stockholm: ECDC; 2016. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publicat...
    1. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53(1):41-4. 10.1111/j.1348-0421.2008.00083.x - DOI - PubMed
    1. Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A, et al. Candida auris: a Review of the Literature. Clin Microbiol Rev. 2017;31(1):e00029-17. 10.1128/CMR.00029-17 - DOI - PMC - PubMed
    1. Spivak ES, Hanson KE. Candida auris: an Emerging Fungal Pathogen. J Clin Microbiol. 2018;56(2):e01588-17. - PMC - PubMed
    1. Lamoth F, Kontoyiannis DP. The Candida auris Alert: Facts and Perspectives. J Infect Dis. 2018;217(4):516-20. 10.1093/infdis/jix597 - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources